Essential Line from ZEISS

Article

Simplicity in basic diagnostics

The new ZEISS Essential Line portfolio of basic diagnostic instruments brings simplicity to your examination workflows – and quality right from the start.

  • Objective refraction

  • IOP and retina screening

  • Slit lamp examination

  • Subjective refraction

Smartly optimize your diagnostic workflow

  • Modular, easily expandable portfolio of basic diagnostic devices

  • Customizable solutions for all practice infrastructures – from single device to complete practice setup, including furnishings

  • DICOM compatibility and clearly defined interfaces for EMR/EHR and PACS

  • Renowned ZEISS quality at an affordable price

  • Comprehensive ZEISS service offerings for quick support and for smooth practice processes

Find out more: www.meditec.zeiss.com/essential-line Contact us: www.meditec.zeiss.com/contacts

 

 

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.